A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliographic Details
Main Author:	Islam, Saidul
Other Authors:	Sharmin, Shahana
Format:	Thesis
Language:	English
Published:	Brac University 2022
Subjects:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Online Access:	http://hdl.handle.net/10361/17308

Similar Items

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
by: Karim, Azrin
Published: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Flora, Sanzida Alam
Published: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
by: Meem, Manila
Published: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
by: Alam, Tahera
Published: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
by: Jahan, Nusrat
Published: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
by: Ahmed, Nafisa
Published: (2023)

Immunotherapy in the Management of Lung Cancer
by: Tasnim, Humayra
Published: (2022)

A review on triple-negative breast cancer and its potential treatment
by: Niasa, Jannatul Ferdous
Published: (2023)

Stem cells as therapeutic carrier in cancer treatment
by: Anika, Mysha Yeasmin
Published: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
by: Hasan, Amit
Published: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
by: Chakraborty, Anuradha
Published: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
by: Khan, Muidul Hasan
Published: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
by: Roy, Hredita
Published: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
by: Emon, Kamrul Hasan
Published: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
by: Mirza, Maisa Tasnim
Published: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
by: Khan, Rezia Nowrin
Published: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
by: Nuha, Nabiha Tahsin
Published: (2024)

Role of statins as antagonists of SPARC in gastric cancer
by: Shahmat, Rad
Published: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
by: Sorno, Rubina Haque
Published: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
by: Ratu, Tabassum
Published: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
by: Choki, Kinley
Published: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
by: Razna, Amrin Islam
Published: (2019)

A comprehensive review on drug repurposing in cancer treatment
by: Sarkar, Onusree
Published: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
by: Mahaleka, Aarshi
Published: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
by: Shaikat, Mahdi Mubin
Published: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
by: Hasan, Sakib
Published: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
by: Nawar, Anika
Published: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
by: Deeba, Maliha Tasnim
Published: (2018)

Targeting BRAFV600E in the treatment of CRC
by: Roja, Mashwiyat Samrin
Published: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
by: Alam, Kazi Tasnuva
Published: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
by: Rahman, Sanjida
Published: (2024)

Biosimilar in lymphoma treatment
by: Tanisha, Mehrin Haque
Published: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
by: Khondokar, Faiza
Published: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
by: Islam, Nahidul
Published: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
by: Beruni, Sajid Mahmud Al
Published: (2022)

Oncogenes: new targets in cancer treatment
by: Chowdhury, Waseka Shams
Published: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
by: Muntaha, Habibatul
Published: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
by: Haque, Mushfiqul
Published: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
by: Karim, Samia Binte
Published: (2024)